Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours – a clinical physics perspective

BACKGROUND: The EORTC has launched a phase II trial to assess safety and efficacy of SBRT for centrally located NSCLC: The EORTC 22113-08113—Lungtech trial. Due to neighbouring critical structures, these tumours remain challenging to treat. To guarantee accordance to protocol and treatment safety, a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Radiat Oncol
Hlavní autoři: Lambrecht, Marie, Melidis, Christos, Sonke, Jan-Jakob, Adebahr, Sonja, Boellaard, Ronald, Verheij, Marcel, Guckenberger, Matthias, Nestle, Ursula, Hurkmans, Coen
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2016
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4721147/
https://ncbi.nlm.nih.gov/pubmed/26791788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-015-0567-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky